These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29411523)

  • 1. First report of the use of long-tapered sirolimus-eluting coronary stent for the treatment of chronic total occlusions with the hybrid algorithm.
    Zivelonghi C; van Kuijk JP; Nijenhuis V; Poletti E; Suttorp MJ; van der Heyden JAS; Eefting FD; Rensing BJ; Ten Berg JM; Azzalini L; van den Brink FS; Ribichini F; Colombo A; Henriques JPS; Agostoni P
    Catheter Cardiovasc Interv; 2018 Nov; 92(5):E299-E307. PubMed ID: 29411523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of Implanting 50-60 mm-Tapered Drug Eluting Stents in Chronic Total Occlusions.
    Miñana G; Consuegra-Sánchez L; Rumiz E; Valero E; García-Blas S; Pernias V; Husser O; Fernández-Cisnal A; Sanchis J; Núñez J
    Cardiovasc Revasc Med; 2019 Dec; 20(12):1117-1122. PubMed ID: 30878362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Multicenter Trial Investigating Angiographic Outcomes of Hybrid Sirolimus-Eluting Stents With Biodegradable Polymer Compared With Everolimus-Eluting Stents With Durable Polymer in Chronic Total Occlusions: The PRISON IV Trial.
    Teeuwen K; van der Schaaf RJ; Adriaenssens T; Koolen JJ; Smits PC; Henriques JP; Vermeersch PH; Tjon Joe Gin RM; Schölzel BE; Kelder JC; Tijssen JG; Agostoni P; Suttorp MJ
    JACC Cardiovasc Interv; 2017 Jan; 10(2):133-143. PubMed ID: 28104206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital-(Research) Registry.
    Shen ZJ; García-García HM; Garg S; Onuma Y; Schenkeveld L; van Domburg RT; Serruys PW;
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):979-86. PubMed ID: 19753636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparison of the efficacy and safety of zotarolimus-eluting stents vs. sirolimus-eluting stents for percutaneous coronary intervention in chronic total occlusion--CAtholic Total Occlusion Study (CATOS) trial.
    Park HJ; Kim HY; Lee JM; Choi YS; Park CS; Kim DB; Her SH; Koh YS; Park MW; Kwon BJ; Kim PJ; Chang K; Chung WS; Seung KB
    Circ J; 2012; 76(4):868-75. PubMed ID: 22277317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiographic and clinical outcomes after recanalization of coronary chronic total occlusions with the Orsiro sirolimus-eluting stent compared with the resolute zotarolimus-eluting stent.
    Markovic S; Lützner M; Dragomir S; Rottbauer W; Wöhrle J
    Coron Artery Dis; 2017 Aug; 28(5):376-380. PubMed ID: 28692458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zotarolimus compared with everolimus eluting stents-angiographic and clinical results after recanalization of true coronary chronic total occlusions.
    Markovic S; Lützner M; Rottbauer W; Wöhrle J
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):18-23. PubMed ID: 26945903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-year clinical outcome after treatment of chronic total occlusions with second-generation drug-eluting stents in the TWENTE trial.
    van Houwelingen KG; Sen H; Lam MK; Tandjung K; Löwik MM; de Man FH; Louwerenburg JH; Stoel MG; Hartmann M; Linssen GC; Doggen CJ; von Birgelen C
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):E76-82. PubMed ID: 25339110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Effectiveness of Everolimus-Eluting Stents in Chronic Total Coronary Occlusion Revascularization: Results From the EXPERT CTO Multicenter Trial (Evaluation of the XIENCE Coronary Stent, Performance, and Technique in Chronic Total Occlusions).
    Kandzari DE; Kini AS; Karmpaliotis D; Moses JW; Tummala PE; Grantham JA; Orr C; Lombardi W; Nicholson WJ; Lembo NJ; Popma JJ; Wang J; Larracas C; Rutledge DR
    JACC Cardiovasc Interv; 2015 May; 8(6):761-769. PubMed ID: 25912400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirolimus-eluting stents in the treatment of chronic total coronary occlusions: results from the prospective multi-center German Cypher Stent Registry.
    Zellerhoff C; Schneider S; Senges J; Pfannebecker T; Hamm C; Tebbe U
    Clin Res Cardiol; 2008 Apr; 97(4):253-9. PubMed ID: 18046523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of percutaneous coronary intervention for chronic total occlusions.
    Mehran R; Claessen BE; Godino C; Dangas GD; Obunai K; Kanwal S; Carlino M; Henriques JP; Di Mario C; Kim YH; Park SJ; Stone GW; Leon MB; Moses JW; Colombo A;
    JACC Cardiovasc Interv; 2011 Sep; 4(9):952-61. PubMed ID: 21939934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised comparison between everolimus-eluting stent and sirolimus-eluting stent in chronic coronary total occlusions. Rationale and design of the CIBELES (non-acute Coronary occlusion treated by EveroLimus-Eluting Stent) trial.
    Moreno R; Garcia E; Teles RC; Almeida MS; Carvalho HC; Sabate M; Martin-Reyes R; Rumoroso JR; Galeote G; Goicolea FJ; Moreu J; Mainar V; Mauri J; Ferreira R; Valdes M; Perez de Prado A; Martin-Yuste V; Jimenez-Valero S; Sanchez-Recalde A; Calvo L; Lopez de Sa E; Macaya C; Lopez-Sendon JL
    EuroIntervention; 2010 May; 6(1):112-6. PubMed ID: 20542806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, predictors, and outcomes of distal vessel expansion on follow-up intravascular ultrasound after recanalization of chronic total occlusions using new-generation drug-eluting stents: Data from the CTO-IVUS randomized trial.
    Hong SJ; Kim BK; Kim YJ; Rha SW; Lee SJ; Kim HY; Choi JH; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Catheter Cardiovasc Interv; 2020 Jan; 95(1):154-164. PubMed ID: 31460693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late catch-up in lumen diameter at five-year angiography in MACE-free patients treated with sirolimus-eluting stents in the Primary Stenting of Totally Occluded Native Coronary Arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II).
    Teeuwen K; Van den Branden BJ; Rahel BM; Laarman GJ; Tijssen JG; Kelder JC; Slagboom T; Ten Berg JM; Suttorp MJ
    EuroIntervention; 2013 Jun; 9(2):212-9. PubMed ID: 23392450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of drug-eluting stents for chronic total occlusions: a systematic review and meta-analysis.
    Saeed B; Kandzari DE; Agostoni P; Lombardi WL; Rangan BV; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2011 Feb; 77(3):315-32. PubMed ID: 20549695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries.
    Wöhrle J; Werner GS
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):793-9. PubMed ID: 22511572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous coronary intervention for a right coronary artery stent occlusion using retrograde delivery of a sirolimus-eluting stent via a septal perforator.
    Utunomiya M; Katoh O; Nakamura S
    Catheter Cardiovasc Interv; 2009 Mar; 73(4):475-80. PubMed ID: 19229979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stent.
    Chen J; Li JJ; Chen JL; Qiao SB; Xu B; Yang YJ; Gao RL; Qin XW; Yuan JQ; Yao M; Wu YJ; Liu HB; Dai J; You SJ
    Coron Artery Dis; 2008 Nov; 19(7):507-11. PubMed ID: 18923247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of resolute zotarolimus-eluting stents and sirolimus-eluting stents in patients with de novo long coronary artery lesions: a randomized LONG-DES IV trial.
    Ahn JM; Park DW; Kim YH; Song H; Cho YR; Kim WJ; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Yun SC; Han S; Lee SY; Lee BK; Cho JH; Yang TH; Lee NH; Yang JY; Park JS; Shin WY; Kim MH; Bae JH; Kim MK; Yoon J; Park SJ
    Circ Cardiovasc Interv; 2012 Oct; 5(5):633-40. PubMed ID: 23048051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioresorbable scaffolds compared with everolimus-eluting stents for the treatment of chronic coronary total occlusion: clinical and angiographic results of a matched paired comparison.
    Kugler C; Markovic S; Rottbauer W; Wöhrle J
    Coron Artery Dis; 2017 Mar; 28(2):120-125. PubMed ID: 27845998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.